Clinical Trial Update: Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression [Phase 2]

View source ↗

Summary

Phase 2 trial of neoadjuvant mFOLFOX plus Alvenor for locally advanced rectal cancer. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Alvenor
• mFOLFOX

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Rectal Cancer Patients, Rectal Cancer Stage II | Phase 2 | Status: NOT_YET_RECRUITING